Fragments for Life
InFarmatik, Inc. Pioneering lnnovation in Fragment Chemistry
The company has been very innovative at Fragment Based Drug Discovery (FBDD). First realized the importance of fragments with designed 3D properties this activity concluded in In3D Fragment Library,
The second milestone was realisation of importance of Targeted Fragment Libraries can guaratee hits on specific ezymes.
As third milestone, INFARMATIK,INC. collaborated with companies to develop GPCR and Kinase inhibitors based on Targeted Fragments. GPR84 antagonist is under patent filing.
Finally in milestone four INFARMATIK,INC. was the first company realized the potential of covalent binding of fargments to proteins and synthesized Covalent Protein Mapping Fragment (CPM) Library.